Precision-based Assessment for the Detection of Mild Cognitive Impairment in Older Adults
Precision-based Assessment for the Detection of Mild Cognitive Impairment in Older Adults
批准号:
10378473
负责人:
Rosie E Curiel Cid
金额:
$58.21万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-04-01 至 2024-01-31
关键词:
AddressAge-YearsAlzheimer disease detectionAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAlzheimer’s disease biomarkerAmyloidApolipoprotein EAtrophicBindingBiologicalBrainBrain regionClinical TrialsCognitionCognitiveCommunitiesComputersConsensusDataDetectionDevelopmentDiseaseEarly identificationElderlyElementsEpidemiologyExhibitsFailureGenotypeHippocampus (Brain)HispanicHornsImmunotherapyImpaired cognitionIndividualInferiorInvestigationLaboratoriesLanguageLateralLearningMagnetic Resonance ImagingMeasurementMeasuresMemory impairmentNerve DegenerationNeuropsychological TestsNeuropsychologyNot Hispanic or LatinoPaperParticipantPatientsPerformancePharmacologyPopulationPrevention strategyPrincipal InvestigatorPropertyPsychometricsRecoverySemanticsSensitivity and SpecificityStressStress TestsSymptomsTabletsTechnologyTestingTimeUnited States National Institutes of HealthWorkaging populationamnestic mild cognitive impairmentbasecerebral atrophyclinical outcome measurescognitive changecognitive systemcognitive testingcohortcomputerizeddesigndiagnostic accuracydiagnostic valueindexinginnovationinstrumentmild cognitive impairmentnext generationnovelpre-clinicalprospective memoryrecruitremote deliveryresearch clinical testingstem
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
There is growing recognition that neurodegenerative brain changes in conditions such as Alzheimer's
disease (AD) occur years before symptoms are currently detected using traditional cognitive assessment
paradigms. These are not sufficiently sensitive to detect the subtle cognitive changes associated with the
condition that occur early in the disease continuum. There is a rising consensus in the field that novel
cognitive assessment paradigms are critically needed to serve as more sensitive clinical outcome measures
in MCI-AD clinical trials. Capturing deficits early is necessary to move the field forward as it makes efforts to
develop both prevention strategies and novel treatment approaches, which are likely to be most effective in
the earliest stages of disease. In addition to the above limitations, widely used paper-and-pencil measures
employed for the detection of AD-related Mild Cognitive Impairment (MCI) require a highly skilled examiner,
and are staff and time intensive. Existing computerized batteries too have their limitations in that many
employ insensitive measurement paradigms, and often are unavailable for diverse cultural/language groups.
Our group are leaders in the field developing “cognitive stress tests,” and have demonstrated that
stressing the cognitive system by eliciting proactive semantic interference (PSI) and then, measuring recovery
from PSI represents a more sensitive approach to detecting cognitive decline during the preclinical stages of
AD. Moreover, vulnerability to PSI and failure to recover from PSI has been highly associated with brain
changes on MRI as well as amyloid load in AD signature regions. These important findings stemming from the
paper-and-pencil versions of our cognitive tests have been refined further by selecting the most sensitive
indices and computerizing the instruments to reduce time and error, and increase accessibility and cross-
cultural applicability.
We propose to recruit 250 community-dwelling older adults to conduct a longitudinal examination of
the utility of three novel computerized cognitive stress tests to detect amnestic Mild Cognitive Impairment
(MCI) versus normal cognition. These novel cognitive tests, the Loewenstein-Acevedo Scales of Semantic
Interference- Brief Computerized version (LASSI-BC), Miami Prospective Memory Test- Computerized
version (MPMT-C), and Miami Test of Semantic Interference and Learning, Extended version (MITSI-LE) will
be compared to ubiquitously used computerized cognitive measures in AD clinical trials among Hispanic and
Non-Hispanic individuals. Further, we will relate performance on these novel measures to regional brain
changes on MRI in AD signature regions, and ApoE genotype. We predict that among individuals with
amnestic MCI, baseline and change scores on the LASSI-BC, MPMT-C, and MITSI-LE will exhibit stronger
associations with increasing brain atrophy on MRI over a three-year period relative to traditional and widely
used computerized neuropsychological measures that are currently available.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
A Brief Version of the LASSI-L Detects Prodromal Alzheimer's Disease States.
LASSI-L 的简要版本可检测阿尔茨海默氏病的前驱状态。
DOI:
10.3233/jad-200790
发表时间:
2020
期刊:
Journal of Alzheimer's disease : JAD
影响因子:
--
作者:
[Crocco,Elizabeth, Curiel-Cid,RosieE, Kitaigorodsky,Marcela, González-Jiménez,ChristianJ, Zheng,Diane, Duara,Ranjan, Loewenstein,DavidA]
通讯作者:
Loewenstein,DavidA
Memory Impairment in Relapsing-Remitting Multiple Sclerosis Using a Challenging Semantic Interference Task.
使用具有挑战性的语义干扰任务来治疗复发缓解型多发性硬化症的记忆损伤。
DOI:
10.3389/fneur.2020.00309
发表时间:
2020
期刊:
Frontiers in neurology
影响因子:
3.4
作者:
[Matias-Guiu,JordiA, Cortés-Martínez,Ana, Curiel,RosieE, Delgado-Álvarez,Alfonso, Fernández-Oliveira,Aníbal, Pytel,Vanesa, Montero,Paloma, Moreno-Ramos,Teresa, Loewenstein,DavidA, Matías-Guiu,Jorge]
通讯作者:
Matías-Guiu,Jorge
DOI:
10.1159/000512804
发表时间:
2021
期刊:
Dementia and geriatric cognitive disorders
影响因子:
2.4
作者:
[Crocco EA, Curiel Cid R, Kitaigorodsky M, Grau GA, Garcia JM, Duara R, Barker W, Chirinos CL, Rodriguez R, Loewenstein DA]
通讯作者:
Loewenstein DA
DOI:
10.1371/journal.pone.0245053
发表时间:
2021
期刊:
PloS one
影响因子:
3.7
作者:
[Zheng DD, Loewenstein DA, Christ SL, Feaster DJ, Lam BL, McCollister KE, Curiel-Cid RE, Lee DJ]
通讯作者:
Lee DJ
DOI:
10.14283/jpad.2021.1
发表时间:
2021
期刊:
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE
影响因子:
6.4
作者:
[Cid, R. E. Curiel, Crocco, E. A., Kitaigorodsky, M., Beaufils, L., Pena, P. A., Grau, G., Visser, U., Loewenstein, D. A.]
通讯作者:
Loewenstein, D. A.
共 9 条
Innovative Deep Phenotyping of African Americans at Risk for Alzheimers disease
-
批准号:10662056
-
项目类别:
-
资助金额:$141.46万
-
财政年份:2023
-
负责人:Rosie E Curiel Cid
-
依托单位:
1Florida Alzheimer's Disease Research Center Outreach, Recruitment and Engagement (ORE) Core
-
批准号:10413195
-
项目类别:
-
资助金额:$34.25万
-
财政年份:2020
-
负责人:Rosie E Curiel Cid
-
依托单位:
1Florida Alzheimer's Disease Research Center Outreach, Recruitment and Engagement (ORE) Core
-
批准号:10190776
-
项目类别:
-
资助金额:$8.53万
-
财政年份:2020
-
负责人:Rosie E Curiel Cid
-
依托单位:
1Florida Alzheimer's Disease Research Center Outreach, Recruitment and Engagement (ORE) Core
-
批准号:9921606
-
项目类别:
-
资助金额:$22.26万
-
财政年份:2020
-
负责人:Rosie E Curiel Cid
-
依托单位:
1Florida Alzheimer's Disease Research Center Outreach, Recruitment and Engagement (ORE) Core
-
批准号:10663239
-
项目类别:
-
资助金额:$22.21万
-
财政年份:2020
-
负责人:Rosie E Curiel Cid
-
依托单位:
Precision-based Assessment for the Detection of Mild Cognitive Impairment in Older Adults
-
批准号:10090546
-
项目类别:
-
资助金额:$58.42万
-
财政年份:2018
-
负责人:Rosie E Curiel Cid
-
依托单位:
海外基金